Suppr超能文献

放射治疗仍然是肿瘤住院治疗的主要成本驱动因素。

Radiation therapy remains the key cost driver of oncology inpatient treatment.

作者信息

Jakovljevic Mihajlo, Zugic Ana, Rankovic Ana, Dagovic Aleksandar

机构信息

Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac , Serbia.

出版信息

J Med Econ. 2015 Jan;18(1):29-36. doi: 10.3111/13696998.2014.971162. Epub 2014 Oct 10.

Abstract

OBJECTIVE

Current radiation therapy capacities in Serbia and most of Eastern Europe are heavily lagging behind population needs. The primary study aim was assessment of direct costs of cancer medical care for patients suffering from cancer with assigned radiotherapy-based treatment protocols. Identification of key cost drivers and trends during 2010-2013 comparing brachytherapy and teleradiotherapy was a secondary objective of the study.

METHODS

Retrospective, bottom-up database analysis was conducted on electronic discharge invoices. Payer's perspective has been adopted with a 1-year long time horizon. Total sample size was 2544 patients during a 4-years long observation period (2010-2013). The sample consisted of all patients with confirmed malignancy disorder receiving inpatient radiation therapy in a large university hospital.

RESULTS

Diagnostics and treatment cost of cancer in the largest Western Balkans market of Serbia were heavily dominated by radiation therapy related direct medical costs. Total costs of care as well as mean cost per patient were steadily decreasing due to budget cuts caused by global recession. The paradox is that at the same time the budget share of radiotherapy increased for almost 15% and in value-based terms for €109 per patient (in total €109,330). Second ranked cost drivers were nursing care and imaging diagnostics. Costs of high-tech visualizing examinations were heavily dominated by nuclear medicine tests.

CONCLUSION

The budget impact of radiation oncology to the large tertiary care university clinics of the Balkans is likely to remain significant in the future. Brachytherapy exhibited a slow growth pattern, while teleradiotherapy remained stable in terms of value-based turnover of medical services. Upcoming heavy investment into the national network of radiotherapy facilities will emphasize the unsatisfied needs. Huge contemporary budget share of radiotherapy coupled with rising cancer prevalence brings this issue into the hot spot of the ongoing cost containment efforts by local governments.

摘要

目的

塞尔维亚及东欧大部分地区目前的放射治疗能力严重滞后于人口需求。本研究的主要目的是评估采用基于放射治疗的治疗方案的癌症患者的癌症医疗直接成本。该研究的次要目的是确定2010 - 2013年期间近距离放射治疗和远距离放射治疗的关键成本驱动因素及趋势。

方法

对电子出院发票进行回顾性的自下而上的数据库分析。采用支付方视角,时间跨度为1年。在4年的观察期(2010 - 2013年)内,总样本量为2544名患者。样本包括在一家大型大学医院接受住院放射治疗的所有确诊恶性疾病患者。

结果

在塞尔维亚这个西巴尔干地区最大的市场,癌症的诊断和治疗成本主要由与放射治疗相关的直接医疗成本主导。由于全球经济衰退导致预算削减,护理总成本以及每位患者的平均成本稳步下降。矛盾的是,与此同时,放射治疗的预算份额增加了近15%,按价值计算每位患者增加了109欧元(总计109,330欧元)。第二大成本驱动因素是护理和影像诊断。高科技可视化检查的成本主要由核医学检查主导。

结论

放射肿瘤学对巴尔干地区大型三级护理大学诊所的预算影响在未来可能仍将很大。近距离放射治疗呈现缓慢增长模式,而远距离放射治疗在医疗服务的基于价值的营业额方面保持稳定。即将对国家放射治疗设施网络进行的大量投资将凸显未得到满足的需求。放射治疗目前巨大的预算份额加上癌症患病率上升,使这个问题成为地方政府当前成本控制努力的热点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验